The Efficacy of Color-Doppler Ultrasonography to Assess the Renal Blood Flow With the Estimation of GFR

Sponsor
University of Roma La Sapienza (Other)
Overall Status
Unknown status
CT.gov ID
NCT00470769
Collaborator
(none)
2,006
3
8
668.7
84.1

Study Details

Study Description

Brief Summary

It is generally assumed that renal blood flow is symmetric in the absence of renal artery stenosis. The importance of studying the function of both kidneys separately is because it cannot be assumed that they are functionally equal.The aim of the present study is to evaluate whether this is really in patients with essential hypertension and/or moderate kidneys loss.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Color-Doppler Ultrasound, 99mTc-DTPA scintigraphy

Detailed Description

To validate color Doppler ultrasonography of renal arteries for the assessment of renal blood flow (RBF), we comparing left and right RBF estimates and their sum (total RBF) by echo-Doppler with data obtained by 99mTc-DTPA scintigraphy in 50 patients with hypertension and/or moderate renal failure, compared with 30 normal control subjects.

Study Design

Study Type:
Observational
Anticipated Enrollment :
2006 participants
Observational Model:
Defined Population
Time Perspective:
Other
Official Title:
Color-Doppler Ultrasonography vs 99mTc-DTPA Scintigraphy to Assess the Renal Blood Flow
Study Start Date :
Sep 1, 2006
Anticipated Study Completion Date :
May 1, 2007

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    30 Years to 80 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Patients with hypertension

    • Patients with moderate renal insufficiency

    • Normal subjects

    Exclusion Criteria:
    • Patients with solitary kidney function

    • Patients with renal artery stenosis

    • Patients underwent renal angioplasty and stenting

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Giorgio Fuiano Catanzaro Italy 88020
    2 University of Rome La Sapienza Roma Italy 00100
    3 Rosario Cianci Rome Italy 00100

    Sponsors and Collaborators

    • University of Roma La Sapienza

    Investigators

    • Principal Investigator: Rosario Cianci, MD, Department Of Clinic Medicine, Chair of Nephrology
    • Study Director: Giorgio Fuiano, MD, University of Catanzaro

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00470769
    Other Study ID Numbers:
    • CR-UR-00001
    First Posted:
    May 8, 2007
    Last Update Posted:
    May 8, 2007
    Last Verified:
    May 1, 2007
    Keywords provided by , ,
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 8, 2007